-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
RespireRx Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2023.
- RespireRx Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 268M shares, a 124% increase year-over-year.
- RespireRx Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2011 was 80M shares, a 8.55% increase from 2010.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)